Bank of Montreal
DFTX

Bank of Montreal’s Definium Therapeutics DFTX Stock Holding History

Bank of Montreal’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229K Buy
12,136
+334
+3% +$5.67K ﹤0.01% 2854
2025
Q4 		$158K Buy
11,802
+405
+4% +$5.01K ﹤0.01% 2916
2025
Q3 		$134K Sell
11,397
-522
-4% -$4.87K ﹤0.01% 2892
2025
Q2 		$77.4K Sell
11,919
-3,186
-21% -$21K ﹤0.01% 3049
2025
Q1 		$88.4K Buy
15,105
+4,438
+42% +$31.8K ﹤0.01% 2944
2024
Q4 		$74.2K Buy
+10,667
New +$73.4K ﹤0.01% 3024
2024
Q3 		– Sell
-33,133
Closed -$240K – 4099
2024
Q2 		$240K Buy
+33,133
New +$290K ﹤0.01% 2881
2022
Q3 		– Sell
-9,901
Closed -$150 – 4284
2022
Q2 		$150 Buy
9,901
+112
+1% +$1.42K ﹤0.01% 3362
2022
Q1 		$175K Buy
9,789
+7
+0.1% +$121 ﹤0.01% 3506
2021
Q4 		$216K Sell
9,782
-1,525
-13% -$48.7K ﹤0.01% 2931
2021
Q3 		$400K Buy
11,307
+1,407
+14% +$60.8K ﹤0.01% 2984
2021
Q2 		$539K Buy
+9,900
New +$520K ﹤0.01% 2791

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of Montreal's DFTX Position: Q1 2026 in Review

Bank of Montreal increased its Definium Therapeutics (DFTX) stake by 2.8% in Q1 2026, buying an estimated $5.67K and bringing the position to 12,136 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #2854.

Bank of Montreal first reported a position in DFTX in Q2 2021 and has held it in 12 quarters since. The position peaked at $539K in Q2 2021. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Bank of Montreal held 12,136 shares of Definium Therapeutics worth $229K as of Q1 2026.
  • Bank of Montreal bought 334 Definium Therapeutics shares in Q1 2026, an estimated $5.67K.
  • Definium Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2854 holding.
  • Bank of Montreal first reported a position in Definium Therapeutics in Q2 2021 and has held it in 12 quarters since.
  • Bank of Montreal's Definium Therapeutics position peaked at $539K in Q2 2021.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.